Search
Lung Cancer | UT Southwestern Medical Center
https://utswmed.org/cancer/cancer-answers/canceranswerssimmons-topics/lung-cancer/
Lung Cancer | UT Southwestern Medical Center
Patient Care | UT Southwestern Medical Center
https://utswmed.org/cancer/cancer-answers/canceranswerssimmons-topics/patient-care/
Patient Care | UT Southwestern Medical Center
Population Science | UT Southwestern Medical Center
https://utswmed.org/cancer/cancer-answers/canceranswerssimmons-topics/population-science/
Population Science | UT Southwestern Medical Center
Research | UT Southwestern Medical Center
https://utswmed.org/cancer/cancer-answers/canceranswerssimmons-topics/research/
Research | UT Southwestern Medical Center
Neuro-Oncology | UT Southwestern Medical Center
https://utswmed.org/cancer/cancer-answers/canceranswerssimmons-topics/neuro-oncology/
Neuro-Oncology | UT Southwestern Medical Center
Prostate Cancer | UT Southwestern Medical Center
https://utswmed.org/cancer/cancer-answers/canceranswerssimmons-topics/prostate-cancer/
Prostate Cancer | UT Southwestern Medical Center
Demystifying Tumor Biology of Hepatocellular Carcinoma | Gastrointestinal Cancer | Population Science | UT Southwestern Medical Center
https://utswmed.org/cancer/cancer-answers/demystifying-tumor-biology-hepatocellular-carcinoma/
UT Southwestern sought to better characterize the tumor biology and natural history of HCC in a U.S. population. Here are the recent findings from this research.
Expanding Eligibility Criteria for Cancer Clinical Trials | Clinical Trials | Lung Cancer | UT Southwestern Medical Center
https://utswmed.org/cancer/cancer-answers/expanding-eligibility-criteria-cancer-clinical-trials/
A history of previous cancer often prevents patients from participating in clinical trials. UT Southwestern is changing this and expanding eligibility.
Enhancing Immunotherapy Drug Trials for Patients with Breast Cancer | Breast Cancer | Clinical Trials | UT Southwestern Medical Center
https://utswmed.org/cancer/cancer-answers/enhancing-immunotherapy-drug-trials-patients-breast-cancer/
When treating a patient with breast cancer, how do we maximally stimulate immune cells to recognize and kill tumor cells? UT Southwestern is finding the answer.
Novel Biomarker Might Lead to Personalized, Targeted Therapy | Gynecologic Cancer | Research | UT Southwestern Medical Center
https://utswmed.org/cancer/cancer-answers/novel-biomarker-might-lead-personalized-targeted-therapy/
ADP-ribosylation could help scientists predict PARP inhibitor sensitivity in ovarian and breast cancer patients. Learn how UT Southwestern is advancing this research.